DOI: 10.25402/fca.19493894.v1
title: Supplementary figures and tables: Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis.docx

description: <b>Supplementary
 Figure 1</b>. Real-world Evidence Comparing Oral Anticoagulants in
 Non-valvular Atrial Fibrillation: A Systematic Review and Network
 Meta-analysis
 
 <b><i>‘Risk of Bias
 Assessment Results by Outcome for Studies Included in Base-case Analysis
 Using Risk of Bias in Non-randomized Studies of Interventions’</i></b>
 <b><i> </i></b>
 <b>Supplementary
 Figure 2. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <b><i>‘Risk of Bias
 Assessment Results by Domain for Studies Included in Base-case Analysis Using
 Risk of Bias in Non-randomized Studies of Interventions’ </i></b>
 <b> </b>
 <b>Supplementary
 Figure 3. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <b><i>‘Network
 Meta-analysis Results for Ischemic Stroke’ </i></b>
 <b> </b>
 <b>Supplementary
 Figure 4. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <b>‘<i>Network Meta-analysis
 Results for Intracranial Hemorrhage’</i></b>
 <b> </b>
 <b>Supplementary
 Figure 5.</b> Real-world Evidence Comparing Oral Anticoagulants in
 Non-valvular Atrial Fibrillation: A Systematic Review and Network
 Meta-analysis
 
 <b><i>‘Network
 Meta-analysis Results for Gastrointestinal Bleeding’</i></b><b><i><br></i></b>
 
 


<b>Supplementary
 Figure 6.</b> Real-world Evidence Comparing Oral Anticoagulants in
 Non-valvular Atrial Fibrillation: A Systematic Review and Network
 Meta-analysis
 
 <b><i>‘Network
 Meta-analysis Results for All-cause Mortality’</i></b>
 <b> </b>
 <b>Supplementary Table
 1. </b> Real-world Evidence Comparing
 Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review
 and Network Meta-analysis
 
 ‘<b><i>Search
 Strategy’</i></b> 
 <b> </b>
 <b>Supplementary
 Table 2. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <b><i>‘Population,
 Interventions and Comparisons, Outcomes, Study Design, and Time Period
 Selection Criteria’</i></b>
 <b> </b>
 <b>Supplementary
 Table 3. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <b><i>‘Process for
 Selecting Data among Kin Publications’</i></b>
 <b><i> </i></b>
 <b>Supplementary
 Table 4. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic
 Review and Network Meta-analysis
 
 <b><i>‘Key
 Characteristics from Studies Included in the Network Meta-analysis’</i></b>
 <b><i> </i></b>
 <b>Supplementary
 Table 5. </b> Real-world Evidence
 Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
 Systematic Review and Network Meta-analysis
 
 <i>‘<b>Outcomes from
 Studies Included in the Network Meta-analysis’</b></i>
 <b> </b>
 <b>PRISMA checklist. </b> Real-world Evidence Comparing Oral
 Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and
 Network Meta-analysis
 
 
 




<b><i>‘PRISMA 2020 Checklist’ </i></b>